As of June 30, 2026, AbbVie Inc. (Symbol: ABBV) was held by 33 hedge funds, with a total share count reduction of approximately 59.56%, down from 1,289,407,765 shares to 521,464,141 shares. The aggregate market value decreased by $767,943,624 from the previous reporting period on March 31, 2026.
Data from the latest batch of 13F filings revealed that 16 funds increased their existing positions in AbbVie, while 14 reduced them. Among notable changes, American Century Companies Inc. decreased its shares by 1,639,495, corresponding to a market value loss of $299,890, whereas Citizens Financial Group Inc. increased its position by 29,800 shares, gaining $13,318 in market value.
This analysis underscores the contrasting investment strategies among hedge funds regarding AbbVie, illustrating broader trends in the biotechnology sector.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
